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The sympathetic nervous system (SNS) is an important contributor to hypertension and other cardiovascular diseases (de Champlain, 1990) . The main effector of the SNS which plays an important role in the regulation of vascular tone is the catecholamine norepinephrine (NE), and to a lesser extent epinephrine (McCulloch and McGrath, 1998) . These vasoactive agents modulate vascular tone by directly acting upon specific receptor proteins present on vascular smooth muscle cells. Alpha-adrenergic receptors play a fundamental role in regulation of systemic arterial blood pressure and blood flow (Piascik and Pérez, 2001 ).
Blood pressure regulation is dependent on total peripheral vascular resistance (TPR) and cardiac output (CO) (Beevers et al., 2001) . Hypertension can result from an increase in either CO or TPR. In established hypertension the usual hemodynamic abnormality is increased TPR (Schobel et al., 1993; Smith et al., 1979; Ferrario et al., 1970) . Since small arteries are the main site of vascular resistance, many studies have compared the ability of NE to contract arteries from normotensive and hypertensive individuals. Data derived from these studies is conflicting. Some have shown an enhanced reactivity of arteries from deoxycorticosterone acetate-salt (DOCA-salt) rats to adrenergic agonists compared to control. (Ekas et al., 1980; Longhurst et al., 1988; Meggs et al., 1988; Perry and Webb, 1988; Suzuki et al., 1994) . Other studies showed that sensitivity to adrenergic agonists is normal in caudal (Hermsmeyer et al., 1982) and mesenteric arteries (Luo et al., 2003) of DOCA-salt rats.
Increased CO also can contribute to increases in blood pressure. The splanchnic bed is a major blood reservoir containing up to 30% of total blood volume (Greenway, JPET #56184 reduction in capacitance of systemic veins will shift blood from peripheral vascular beds towards the thoracic cavity (Ricksten et al., 1981) . In this way, augmented venous return leads to higher stroke volume and cardiac output (CO). Data from animal and human studies support a role for decreased venous capacitance in the development of hypertension as increased CO often occurs in the initial stages of experimental hypertension (Ferrario et al., 1970; Smith et al., 1979) as well as in the early stages of human hypertension (Schobel et al., 1993) .
Mean circulatory filling pressure (MCFP) is the effective driving force for venous return to the heart. MCFP is elevated in renal hypertensive dogs, 2-kidney, 1-clip hypertensive rats, spontaneously hypertensive rats and in the DOCA-salt hypertensive rats (Ferrario et al., 1970; Edmunds et al., 1989; Martin et al., 1998; Fink et al., 2000) .
MCFP is dependent on venoconstrictor tone and blood volume. Most studies done in animals and hypertensive humans have revealed that blood volume does not increase in hypertension (Schobel at al., 1993; Ferrario et al., 1970) . Therefore, increased MCFP in hypertension development is primarily due to venoconstriction. Multiple factors determine venomotor tone but sympathetic-mediated vasoconstriction is the most important (Pang, 2001) . However, little is known about venous reactivity to NE in hypertension.
We sought to test the hypothesis that increased venoconstriction in hypertension is due to enhanced reactivity to NE. We studied vascular reactivity in a murine model of DOCA-salt hypertension. In this salt-sensitive, low renin experimental model, SNS activity has been found to play an important part (de Champlain, 1990 ) and venous capacitance has been shown to be decreased by the SNS as determined by changes in JPET #56184 6 MCFP (Fink et al., 2000) , making this hypertension model relevant for the studies performed here. Furthermore, α 1 adrenoceptor antagonists are effective antihypertensive agents in DOCA-salt hypertension (Nabata et al., 1985) .
We compared acute reactivity and time-dependent desensitization to α adrenergic agonists in small arteries and veins of DOCA-salt and SHAM control mice. We did these studies because if altered vascular responses to NE contribute to hypertension (a chronic condition), those responses should be either larger, or more sustained in vessels from hypertensive versus normotensive rats. We also examined potential mechanisms behind differences in vascular reactivity of arteries and veins.

Materials and Methods
Animals: C57/BL male mice (25-30g) used in these experiments were obtained from Charles River Labs (Portage, MI) . Upon arrival at the animal care facility, mice were maintained according to the standards approved by the Michigan State University All-University Committee on Animal Use and Care. Mice were individually housed in clear plastic cages with free access to standard pelleted chow (Harlan/Teklad 8640 Rodent Diet) and tap water. Mice were housed in temperature and humidity-controlled rooms with a 12 hours on/12 hours off light cycle. Animals were allowed a period of 2-3 days of acclimatization prior to entry into any experimental protocol.
DOCA-salt surgery:
Mice were unilaterally nephrectomized under anesthesia provided by intraperitoneal injection of approximately 70 -80 µL of a solution containing ketamine (100 mg/mL) and xylazine (20 mg/mL) in a 9:1 ratio, respectively.
The skin over the left flank was shaved and a 1.5 cm incision was made through the skin and underlying muscle caudal to the rib cage. The left kidney was exteriorized and removed after ligation of the renal artery and vein with 4-0 silk sutures (Ethicon, Inc, Somerville, NJ). The muscle and skin layers were then closed separately with 4-0 silk sutures. A small area between the shoulder blades of the back was shaved and a 1 cm incision was made through which DOCA-salt pellets were implanted subcutaneously resulting in a dose of 150 mg/kg DOCA. All DOCA mice were given salt water containing 1% NaCl and 0.2% KCl. Normotensive SHAM mice were also unilaterally nephrectomized, received no DOCA pellet implantation, and were given tap water. Both groups were placed on standard pelleted rodent chow. After recovery, the mice were JPET #56184 housed under standard conditions for 4 weeks after which systolic BP was determined by the tail-cuff method.
In-vitro preparation of mesenteric vessels: Mice were anesthetized and the small intestine with its associated mesenteric vessels was removed and placed in oxygenated (95% oxygen, 5% carbon dioxide) Krebs' physiological saline solution of the following composition (mmol): NaCl 117, KCl 4.7, CaCl 2 2.5, MgCl 2 1.2, NaHCO 3 25, glucose 11. A segment of the intestine with associated vessels was removed and pinned flat in a silicone elastomer-lined (Sylgard, Dow Corning) petri dish. A section of mesentery containing vessels close to the mesenteric border was cut out using fine scissors and forceps. The preparation was transferred to a smaller silicone elastomer-lined recording bath and pinned flat. Second or third-order mesenteric veins or arteries (100-200 µm diameter) were isolated for study by carefully clearing away the surrounding fat tissue. The recording bath containing the preparation was mounted on the stage of an inverted microscope (Olympus CK-2) and superfused with warm (37 °C) Krebs' solution at a flow rate of 7 mL/min. All preparations were allowed a 20 minute equilibration period during which the vessels relaxed to a stable resting diameter. Desensitization studies: Mesenteric vessels were taken from SHAM and DOCAsalt mice, isolated and prepared as described in the sections above. In this series of experiments, vasoconstriction of arteries and veins was examined using NE (veins: 10 -6 M; arteries: 10 -5 M) and PE (veins/arteries: 10 -5 M) concentrations which elicited maximal constrictions in these vessels. The adrenergic agonist was continuously applied to the superfusing Krebs' solution and blood vessels were exposed to the adrenergic agonist for 30 minutes. The vasoconstrictor state of arteries and veins at different time points was examined.
Effect of phenoxybenzamine (PBZ) on NE-or PE-elicited initial constriction
and the vasoconstrictor reactivity of mesenteric arteries and veins upon a 30 minute incubation period with adrenergic agonists: The PBZ-pretreatment protocol was done according to a previously published protocols (Watts et al., 1996) . After the initial 20 minute equilibration period, tissues were incubated for 10 minutes with one concentration 
where E min is the minimum response and was constrained to zero, n is the slope factor.
All data is expressed as mean ± SEM. Statistical differences between groups was assessed by Student's two-tailed unpaired t-test. When more than two groups were compared, an analysis of variance (ANOVA) was used with Student-Newman-Keuls multiple comparison as a post test. P < 0.05 was considered statistically significant. All statistical analyses were performed using GraphPad InStat for Windows 95 (GraphPad Software, San Diego, CA).
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Results
General. Four weeks after the start of DOCA-salt treatment, systolic blood pressure in the DOCA-salt treated mice (n = 56) was significantly higher than systolic blood pressure in the SHAM (n = 47) control mice (123 ± 1 mmHg -vs-101 ± 1 mmHg, P<0.05). In agreement with other studies documenting hypertrophy of kidneys and cardiac ventricles of DOCA-salt rats (Young et al.,1994) and mice (Peng et al., 2001 ), kidney and ventricular weight when normalized for body weight, were higher in the DOCA-salt treated group (10.0 ± 0.2 mg/g body weight -vs-8.1 ± 0.1 mg/g body weight and 4.7 ± 0.1 mg/g body weight -vs-4.0 ± 0.09 mg/g body weight, respectively, P<0.05).
The inner diameter of mesenteric arteries from SHAM and DOCA-salt mice was 154 ± 8.1 µm and 166.2 ± 6.9 µm, respectively (P>0.05). The diameter of mesenteric veins from SHAM and DOCA-salt mice was 193.7 ± 3.2 µm and 169.8 ± 5.1 µm, respectively (P<0.05). and arteries (10 -7 -3x10 -5 M) in both treatment groups (Fig. 1B ). NE and PE were both more potent in constricting mesenteric veins from SHAM and DOCA-salt mice as there was a leftward shift in the concentration-response curve obtained in veins when compared to arteries (Fig.1A, Fig. 1B , Table 1 ). However, the magnitudes of responses of JPET #56184
veins and arteries to various doses of NE and PE were similar between DOCA-salt and SHAM groups (Fig. 1A, Fig. 1B , Table 1 ).
The role of α 2 adrenergic receptors in mediating vasoconstriction of arteries and veins from DOCA-salt and SHAM control mice was assessed. The α 2 adrenoceptor agonists clonidine (10 -7 M -10 -5 M) and UK 14,304 (10 -7 M -10 -5 M) did not elicit constrictions in mesenteric arteries or veins from SHAM and DOCA-salt mice.
Differential desensitization in arteries and veins. Our concentration-response studies showed that murine mesenteric veins were more sensitive than arteries to the constrictor effects of NE and PE. Mesenteric arteries exhibited similar maximal responses but higher concentrations were needed to achieve them. Given those differences, we decided to further examine the potential mechanisms behind the marked differences in reactivity between mesenteric arteries and veins to adrenergic stimulation. This next series of experiments explored whether arteries and veins desensitize in a similar way when exposed to maximum concentrations of NE and PE. The concentrations used in this series of experiments were those responsible for inducing a maximal response in arteries and veins according to our concentration-response studies (Fig. 1 ). NE produced an initial peak constriction in both arteries (10 -5 M) and veins (10 -6 M) from DOCA-salt and SHAM control mice ( Fig. 2A, Fig. 2B ). However, arteries exhibited a time-dependent desensitization as their diameter returned to the initial resting diameter during the 30 minute agonist application (Fig. 2B ). This effect was more prominent in SHAM arteries compared to DOCA-salt arteries. After 30 minutes of continuous agonist exposure, the diameter of SHAM arteries was about 10% of the initial peak constriction caused by NE while in DOCA-salt arteries the response declined to about 50% of the initial peak (Fig. 3A) . However, mesenteric veins maintained a tonic constriction despite continuous exposure to NE (Fig. 2A) . After 30 minutes exposure, DOCA-salt and SHAM vein diameter was about 80% of the initial peak constriction elicited by NE (Fig. 3A) .
Continuous exposure of arteries and veins to the selective α 1 adrenergic receptor agonist PE (10 -5 M) revealed a marked difference between mesenteric arteries and veins.
Incubation with PE elicited a constriction in arteries and veins (Fig. 2C, Fig. 2D ). PE responses in DOCA-salt and SHAM arteries (Fig. 3B ) completely desensitized upon continuous exposure to PE. However, after 30 minute exposure to PE the diameter of DOCA-salt and SHAM veins was between 80-90% of the initial peak constriction (Fig.   3B ).
α-Adrenoceptor alkylation studies with phenoxybenzamine (PBZ): effects on agonist-induced initial constriction. To further determine whether the increased reactivity to adrenergic agonists seen in veins was due to differences in adrenergic receptor concentrations, we incubated the vessels with the α-adrenoceptor alkylating agent PBZ (0.3, 3, 10 and 30 nM) and compared the effects on the NE-or PE-elicited initial peak constriction. Incubation of SHAM veins with PBZ (0.3 nM) did not affect their initial constriction in response to NE (Fig. 4A) . However, higher PBZ concentrations (3, 10 and 30 nM) produced a significant concentration-dependent reduction in the NE-elicited peak constriction (Fig. 4A) . DOCA-salt mesenteric veins were more resistant to PBZ alkylating effects as the peak contractile response to NE was significantly inhibited only at the highest (30 nM) PBZ concentration (Fig. 4A) .
Preincubation of SHAM veins with PBZ (0.3 nM) did not affect the peak constriction elicited by PE compared to control responses (Fig. 4B) . However, incubation with higher concentrations (3, 10 and 30 nM) of PBZ significantly inhibited peak constriction (Fig. 4B) . A similar inhibition was seen in DOCA-salt veins (Fig. 4B) as PBZ (0.3 nM) did not affect the peak contractile response seen after PE application compared to veins not exposed to PBZ. However, incubation at the higher doses (3, 10 and 30 nM) significantly inhibited the peakl contractile response (Fig. 4B) .
Incubation of SHAM control and DOCA-salt mesenteric arteries with all PBZ concentrations completely inhibited their contractile response to NE (Fig. 4A ). All PBZ concentrations blocked PE-induced constrictions of SHAM and DOCA-salt arteries (Fig.   4B ).
Effects of α-adrenoceptor alkylation with PBZ on desensitization. The ability of 30 minutes exposure to NE to desensitize mesenteric veins preincubated with different concentrations of the alkylating agent PBZ was assessed. As preincubation with any PBZ concentration completely inhibited contractile responses in arteries, these studies were not performed in arteries. PBZ (0.3 nM) pretreatment did not change reactivity of SHAM veins to NE applied for 30 minutes, as NE caused a sustained constriction (Fig. 5A ). In contrast, veins pre-incubated with PBZ (3nM) were not able to maintain a contractile response throughout the 30 minute period when compared to non PBZ-treated veins (Fig.   5A ). As 10 and 30nM PBZ markedly reduced the peak NE-induced constriction in SHAM veins (Fig. 4A) , we could not assess desensitization in these tissues. DOCA-salt veins were more resistant to the PBZ inhibitory effect since only veins incubated with the highest PBZ concentration (30nM) failed to maintain contractility to NE applied for 30 minutes (Fig. 5B) . As PE was much less efficacious than NE in stimulating constriction
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Adrenergic vascular reactivity is not altered in DOCA-salt mice. Vascular reactivity of arteries and veins to α 1 adrenoceptor stimulation is not altered in DOCA-salt compared to SHAM. Despite the difference in resting venous diameter between SHAM control and DOCA-salt veins, vascular reactivity was not altered. In agreement with our data, NE responses of subcutaneous veins taken from hypertensive patients were unchanged compared to control subjects (Lind et al., 1997) . However, studies done in DOCA-salt rats showed that mesenteric arterial adrenergic reactivity is enhanced compared to SHAM rats (Suzuki et al., 1994; Longhurst et al., 1988; Perry and Webb, 1988; Ekas and Lokhandwala, 1980) . This discrepancy could be due to the differences in size of the vessels studied or the different methods used to assess vascular reactivity. (Douglas et al., 2000) . Our studies agree with those in caudal arteries (Hermsmeyer et al., 1982) and mesenteric arteries and veins (Luo et al., 2003) which show that the reactivity to adrenergic agonists does not change in DOCA-salt rats.
Suzuki et al. (1994), Longhurst et al. (1988) and Ekas and Lokhandwala (1980) measured
Veins are more sensitive to the vasoconstrictive effects of NE and PE. We showed that veins are more sensitive than arteries to adrenergic stimulation. It could be argued that increased venous reactivity is due the fact that these experiments were carried out in unpressurized vessels and arteries and veins have different flow-pressure characteristics. However, previous studies have demonstrated that the increased sensitivity of mesenteric veins compared to arteries to either adrenergic agonists (Naito et al., 1998) or to sympathetic nerve stimulation (Hottenstein and Kreulen, 1987 ) is maintained when arteries and veins were pressurized to physiological levels. Therefore, increased venous adrenergic reactivity compared to arteries is not a function of vessels pressure.
Given this increased sensitivity of veins to adrenergic agonists, we tested the hypothesis that the increased adrenergic reactivity of veins is due to a larger α 1 -adrenoceptor concentration. The α-adrenoceptor alkylating agent PBZ was used to assess receptor reserve in arteries and veins. The initial NE-elicited constriction was reduced by Veins are resistant to desensitization. An increased α-adrenoceptor population in veins led us to predict that veins would be more resistant to desensitization than arteries. Arteries exhibited a time-dependent desensitization by NE that was more prominent in vessels taken from SHAM mice. In response to continuous exposure to PE, arteries from SHAM and DOCA-salt mice desensitized completely. Desensitization in arteries was more prominent when the vessels were exposed to PE than when exposed to NE suggesting that α 2 -mediated constriction elicited by NE could offset desensitization of α 1 adrenoceptors. However, α 2 -adrenoceptors do not play a direct vasoconstrictive role in the small arteries and veins studied here (see above). Upregulation of α 1 adrenoceptors in DOCA-salt mesenteric arteries could explain why there was not a complete desensitization of these vessels in response to continuous exposure to NE. Upregulation of α 1 -adrenoceptors occurs in mesenteric arteries of DOCA-salt rats (Meggs et al., 1988) .
Given this, DOCA-salt arteries should be more resistant to α 1 -adrenoceptor desensitization than SHAM arteries upon exposure to PE. That was not found as both groups of arteries completely desensitized.
Increased post-receptor activation events in DOCA-salt arteries could account for the relative resistance to desensitization seen in those vessels. Phosphatidylinositol activity was found to be greater in mesenteric (Takata et al., 1989) and femoral arteries of DOCA-salt rats with no apparent change in receptor number or binding affinity (Eid and de Champlain, 1988 and α 1B but not α 1D adrenoceptors. Internalization was faster for the α 1B subtype. As there are differences in desensitization and internalization properties of α 1 -adrenoceptors, it will be important to identify the subtype expression in murine mesenteric vessels and to determine if expression changes in DOCA-salt hypertension.
PBZ-pretreated veins are susceptible to desensitization. Our studies suggest that there is an increased α 1 -adrenoceptor concentration in veins compared to arteries.
The increased receptor concentration could account for the relative resistance of veins to desensitization. We hypothesized that decreasing the α 1 -adrenoceptor reserve in veins would render them more susceptible to desensitization by adrenergic agonists. PBZtreated veins showed a partial desensitization to NE exposure similar to that seen in arteries. PBZ-treated SHAM veins were more susceptible to desensitization compared to DOCA-salt veins, which only desensitized after treatment with the highest PBZ concentration. These results suggest that veins have an increased α-adrenoceptor JPET #56184 population compared to arteries and that there is an upregulation in DOCA-salt veins compared to SHAM veins.
Responses to PE in PBZ-treated vessels were also inhibited in SHAM and DOCA-salt veins. However, the inhibition seen in these vessels was greater than that seen in PBZ-treated veins subsequently challenged with NE. Inhibition of PE responses between SHAM and DOCA-salt veins upon PBZ pretreatment did not differ. However, responses to PE were completely abolished in mesenteric arteries previously treated with any PBZ concentration. PE may be less efficacious than NE in stimulating constrictions in mesenteric vessels and this could explain the greater sensitivity to PBZ in veins challenged with PE. 
